Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nielsen

Showing results (841-850 of 1,004) with videos related to

Pageof 101
Sort By:
Cell|January 12, 2022
Engineered virus-like particles for efficient in vivo delivery of therapeutic proteinsSamagya Banskota, Aditya Raguram, Susie Suh, et al.
American Heart Journal|June 20, 2017
Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trialRenato D Lopes, Marco Alings, Stuart J Connolly, et al.
Genes, Chromosomes & Cancer|January 22, 2009
Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndromeJianghua Ou, Merete Rasmussen, Helga Westers, et al.
Frontiers in Pediatrics|May 8, 2018
Importance of Comprehensive Molecular Profiling for Clinical Outcome in Children With Recurrent CancerOlga Østrup, Karsten Nysom, David Scheie, et al.
BMC Cancer|July 22, 2018
Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencingM B Mogensen, M Rossing, O Østrup, et al.
Breast Cancer Research and Treatment|December 25, 2010
A BRCA2 mutation incorrectly mapped in the original BRCA2 reference sequence, is a common West Danish founder mutation disrupting mRNA splicingMads Thomassen, Inge Søkilde Pedersen, Ida Vogel, et al.
European Journal of Heart Failure|May 11, 2024
New York Heart Association functional class and implantable cardioverter-defibrillator in non-ischaemic heart failure with reduced ejection fraction: Extended follow-up of the DANISH trialMunise N Karacan, Seiko N Doi, Adelina Yafasova, et al.
Journal of Cardiac Failure|May 16, 2024
Effect of Implantable Cardioverter-defibrillators in Nonischemic Heart Failure According to Background Medical Therapy: Extended Follow-up of the DANISH TrialAdelina Yafasova, Seiko N Doi, Jens Jakob Thune, et al.
Heart (British Cardiac Society)|June 29, 2024
Healthcare utilisation and quality of life according to atrial fibrillation burden, episode frequency and durationMaria Hee Jung Park Frausing, Martijn Van De Lande, Dominik Linz, et al.
Journal of the American College of Cardiology|October 22, 2025
Long-Term Effect of ICDs in Nonischemic Heart Failure With Reduced Ejection Fraction: Extended Follow-Up Analysis of DANISHJawad H Butt, Seiko N Doi, Jens J Thune, et al.
Pageof 101

Showing results (841-850 of 1,004) with videos related to

Sort By:
Pageof 101
Cell|January 12, 2022
Engineered virus-like particles for efficient in vivo delivery of therapeutic proteinsSamagya Banskota, Aditya Raguram, Susie Suh, et al.
American Heart Journal|June 20, 2017
Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trialRenato D Lopes, Marco Alings, Stuart J Connolly, et al.
Genes, Chromosomes & Cancer|January 22, 2009
Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndromeJianghua Ou, Merete Rasmussen, Helga Westers, et al.
Frontiers in Pediatrics|May 8, 2018
Importance of Comprehensive Molecular Profiling for Clinical Outcome in Children With Recurrent CancerOlga Østrup, Karsten Nysom, David Scheie, et al.
BMC Cancer|July 22, 2018
Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencingM B Mogensen, M Rossing, O Østrup, et al.
Breast Cancer Research and Treatment|December 25, 2010
A BRCA2 mutation incorrectly mapped in the original BRCA2 reference sequence, is a common West Danish founder mutation disrupting mRNA splicingMads Thomassen, Inge Søkilde Pedersen, Ida Vogel, et al.
European Journal of Heart Failure|May 11, 2024
New York Heart Association functional class and implantable cardioverter-defibrillator in non-ischaemic heart failure with reduced ejection fraction: Extended follow-up of the DANISH trialMunise N Karacan, Seiko N Doi, Adelina Yafasova, et al.
Journal of Cardiac Failure|May 16, 2024
Effect of Implantable Cardioverter-defibrillators in Nonischemic Heart Failure According to Background Medical Therapy: Extended Follow-up of the DANISH TrialAdelina Yafasova, Seiko N Doi, Jens Jakob Thune, et al.
Heart (British Cardiac Society)|June 29, 2024
Healthcare utilisation and quality of life according to atrial fibrillation burden, episode frequency and durationMaria Hee Jung Park Frausing, Martijn Van De Lande, Dominik Linz, et al.
Journal of the American College of Cardiology|October 22, 2025
Long-Term Effect of ICDs in Nonischemic Heart Failure With Reduced Ejection Fraction: Extended Follow-Up Analysis of DANISHJawad H Butt, Seiko N Doi, Jens J Thune, et al.
Pageof 101